Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.31 |
| ▸ | MEN1 | O00255 | 4/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | CTSB | P07858 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
| ▸ | TDO2 | P48775 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 4/20 | 0.30 |
| ▸ | TP53 | P04637 | 3/20 | 0.30 |
| ▸ | HTT | P42858 | 3/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.30 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.30 |
| ▸ | USP2 | O75604 | 2/20 | 0.30 |
| ▸ | ALOX15B | O15296 | 1/20 | 0.30 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8546749 | 0.82 | — | — | |
| SCHEMBL29668444 | 0.77 | — | — | |
| SCHEMBL2281792 | 0.77 | — | — | |
| SCHEMBL5048673 | 0.74 | ALDH1A1 (0.36) | ALDH1A1TDP1LMNAALOX15MMP9 | |
| SCHEMBL1507622 | 0.74 | ALDH1A1 (0.49) | KDM4EMEN1KMT2AALDH1A1MAPT | |
| SCHEMBL1461333 | 0.72 | — | — | |
| SCHEMBL29668398 | 0.72 | — | — | |
| SCHEMBL15614439 | 0.72 | — | — | |
| SCHEMBL2285780 | 0.72 | — | — | |
| SCHEMBL6130237 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116102725-B | Preparation method of flame-retardant polycarbonate polyol | 万华化学集团股份有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-116102725-A | Preparation method of flame-retardant polycarbonate polyol | 万华化学集团股份有限公司 | 2023-05-12 | — | — | CN | claimed |
| US-12628491-B2 | Organic-inorganic adhesion layer and its use in perovskite solar cells and modules | Tandem PV (US) | 2026-05-12 | — | — | US | disclosed |
| CN-116102725-B | Preparation method of flame-retardant polycarbonate polyol | 万华化学集团股份有限公司 | 2025-04-01 | — | — | CN | disclosed |
| WO-2024081751-A1 | ORGANIC-INORGANIC ADHESION LAYER AND ITS USE IN PEROVSKITE SOLAR CELLS AND MODULES | Tandem PV (US) | 2024-04-18 | — | — | WO | disclosed |
| US-20240121970-A1 | ORGANIC-INORGANIC ADHESION LAYER AND ITS USE IN PEROVSKITE SOLAR CELLS AND MODULES | Tandem PV | 2024-04-11 | — | — | US | disclosed |
| CN-116102725-A | Preparation method of flame-retardant polycarbonate polyol | 万华化学集团股份有限公司 | 2023-05-12 | — | — | CN | disclosed |
| WO-2020125238-A1 | PLATINUM (II) TETRADENTATE ONNO COMPLEX LUMINESCENT MATERIAL, PREPARATION METHOD, AND APPLICATION THEREOF IN ORGANIC LIGHT EMITTING DIODE | 广东阿格蕾雅光电材料有限公司 | 2020-06-25 | — | — | WO | disclosed |
| US-8227093-B2 | Cyclometalated transition metal complex and organic electroluminescence device using the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2012-07-24 | — | — | US | disclosed |
| US-20090186864-A1 | RUTHENIUM (II) COMPOUNDS | THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) | 2009-07-23 | — | — | US | disclosed |
| EP-2056801-A1 | RUTHENIUM II COMPOUNDS | The University Court of the University of Edinburgh (GB) | 2009-05-13 | — | — | EP | disclosed |
| JP-2008069123-A | MANUFACTURING METHOD OF HYDROXYPYRIDINE N-OXIDE DERIVATIVE, BIPYRIDINE DIOL DERIVATIVE AND DIHALOBIPYRIDINE DERIVATIVE | KONICA MINOLTA HOLDINGS INC | 2008-03-27 | — | — | JP | disclosed |
| US-20080058579-A1 | Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors | ANGIOTECH INTERNATIONAL AG (CH) | 2008-03-06 | — | — | US | disclosed |
| WO-2007135410-A1 | RUTHENIUM II COMPOUNDS | THE UNIVERSITY COURT OF THE UNVERSITY OF EDINBURGH (GB) | 2007-11-29 | — | — | WO | disclosed |
| US-20070190358-A1 | Cyclometalated transition metal complex and organic electroluminescence device using the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2007-08-16 | — | — | US | disclosed |
| US-20030144570-A1 | Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors | ANGIOTECH PHARMACEUTICALS, INC. (CA) | 2003-07-31 | — | — | US | disclosed |
| US-20020055666-A1 | Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors | ANGIOTECH INTERNATIONAL AG (CH) | 2002-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186864-A1 | RUTHENIUM (II) COMPOUNDS | CBR3, RRS1, CBR1 | KDM4E 4199/4885MEN1 2867/4885KMT2A 3882/4885 |
| US-12628491-B2 | Organic-inorganic adhesion layer and its use in perovskite solar cells and modules | EPCAM, CDH1, L1CAM | KDM4E 739/4885MEN1 1118/4885KMT2A 629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.